Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription 20.09.2021 6 Ann Intern Med 2 Arch Virol 1 Biochem Soc Trans 7 BMJ 2 Cell 5 J Epidemiol Community Health 1 J Exp Med 1 J Gen Virol 1 J Immunol 3 J Infect Dis 1 J Virol 18 Lancet 5 MMWR Morb Mortal Wkly Rep 7 N Engl J Med 10 Pediatrics 1 PLoS Comput Biol 11 PLoS One 6 Proc Natl Acad Sci U S A 2 Vaccine 2 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. SPINELLI MA, Glidden DV, Gennatas ED, Rutherford GW, et al
   Effectiveness of Adding a Mask Recommendation to Other Public Health Measures.
   Ann Intern Med. 2021;174:1193.
   PubMed        
   
   
2. MORAN B
   Effectiveness of Adding a Mask Recommendation to Other Public Health Measures.
   Ann Intern Med. 2021;174:1192-1193.
   PubMed        
   
   
3. LLOR C
   Effectiveness of Adding a Mask Recommendation to Other Public Health Measures.
   Ann Intern Med. 2021;174:1194.
   PubMed        
   
   
4. GAINES H
   Effectiveness of Adding a Mask Recommendation to Other Public Health Measures.
   Ann Intern Med. 2021;174:1193.
   PubMed        
   
   
5. BUNDGAARD H, Ringgaard AK, Raaschou-Pedersen DET, Bundgaard JS, et al
   Effectiveness of Adding a Mask Recommendation to Other Public Health Measures.
   Ann Intern Med. 2021;174:1194-1195.
   PubMed        
   
   
6. RAND J
   Effectiveness of Adding a Mask Recommendation to Other Public Health Measures.
   Ann Intern Med. 2021;174:1194.
   PubMed        
   
   

   
   Arch Virol

7. HU J, Stojanovic J, Yasamineh S, Yasamineh P, et al
   The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.
   Arch Virol. 2021;166:2649-2672.
   PubMed         Abstract available
   
   
8. DOMNICH A, De Pace V, Pennati BM, Caligiuri P, et al
   Evaluation of extraction-free RT-qPCR methods for SARS-CoV-2 diagnostics.
   Arch Virol. 2021;166:2825-2828.
   PubMed         Abstract available
   
   

   
   Biochem Soc Trans

9. HOCH NC
   Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
   Biochem Soc Trans. 2021;49:1711-1721.
   PubMed         Abstract available
   
   

   
   BMJ

10. SEEDAT S, Rondon M
    Women's wellbeing and the burden of unpaid work.
    BMJ. 2021;374:n1972.
    PubMed        
    
    
11. GOYAL DK
    Improve care pathways for covid now to do better when the next variant or pandemic hits.
    BMJ. 2021;374:n2138.
    PubMed        
    
    
12. PAGEL C
    Schools: a gaping hole in England's covid strategy.
    BMJ. 2021;374:n2115.
    PubMed        
    
    
13. FALLOWS ESV
    Covid-19 and GPs: the unmeasured goes unnoticed.
    BMJ. 2021;374:n2140.
    PubMed        
    
    
14. SIDEBOTTOM DB, Gill D
    Ronapreve for prophylaxis and treatment of covid-19.
    BMJ. 2021;374:n2136.
    PubMed        
    
    
15. TANCREDI S, Anker D, Rosella L, Chiolero A, et al
    Elimination of covid-19: beware of surveillance bias.
    BMJ. 2021;374:n2126.
    PubMed        
    
    
16. JONES CW
    Primary care backlog will add to urgent care pressures over time.
    BMJ. 2021;374:n2178.
    PubMed        
    
    

    
    Cell

17. ZIEGLER CGK, Miao VN, Owings AH, Navia AW, et al
    Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
    Cell. 2021;184:4713-4733.
    PubMed         Abstract available
    
    
18. MANN ME, Hall LJ, Dulvy NK
    Scientific impact in a changing world.
    Cell. 2021;184:1407-1408.
    PubMed         Abstract available
    
    

    
    J Epidemiol Community Health

19. BERGMANS RS, Larson PS
    Suicide attempt and intentional self-harm during the earlier phase of the COVID-19 pandemic in Washtenaw County, Michigan.
    J Epidemiol Community Health. 2021;75:963-969.
    PubMed         Abstract available
    
    
20. SILVA J, Ribeiro-Alves M
    Social inequalities and the pandemic of COVID-19: the case of Rio de Janeiro.
    J Epidemiol Community Health. 2021;75:975-979.
    PubMed         Abstract available
    
    
21. TOPRICEANU CC, Wong A, Moon JC, Hughes AD, et al
    Impact of lockdown on key workers: findings from the COVID-19 survey in four UK national longitudinal studies.
    J Epidemiol Community Health. 2021;75:955-962.
    PubMed         Abstract available
    
    
22. KATIKIREDDI SV, Lal S, Carrol ED, Niedzwiedz CL, et al
    Unequal impact of the COVID-19 crisis on minority ethnic groups: a framework for understanding and addressing inequalities.
    J Epidemiol Community Health. 2021;75:970-974.
    PubMed         Abstract available
    
    
23. POWELL RA, Kendall K, Cislaghi B, El-Osta A, et al
    Self-care, social norms and anomie during COVID-19: from contestation of the greater good to building future normative resilience in the UK.
    J Epidemiol Community Health. 2021;75:925-926.
    PubMed        
    
    

    
    J Exp Med

24. NIMMERJAHN F, Ravetch JV
    Four keys to unlock IgG.
    J Exp Med. 2021;218.
    PubMed         Abstract available
    
    

    
    J Gen Virol

25. STALLER E, Sheppard CM, Baillon L, Frise R, et al
    A natural variant in ANP32B impairs influenza virus replication in human cells.
    J Gen Virol. 2021;102.
    PubMed         Abstract available
    
    

    
    J Immunol

26. ALVES I, Vicente MM, Gaifem J, Fernandes A, et al
    SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.
    J Immunol. 2021;207:1591-1598.
    PubMed         Abstract available
    
    

    
    J Infect Dis

27. BRAUNSTEIN SL, Slutsker JS, Lazar R, Shah D, et al
    Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City.
    J Infect Dis. 2021 Jun 16. pii: 6301136. doi: 10.1093.
    PubMed         Abstract available
    
    
28. NOH JY, Kwak JE, Yang JS, Hwang SY, et al
    Longitudinal Assessment of Antisevere Acute Respiratory Syndrome Coronavirus 2 Immune Responses for Six Months Based on the Clinical Severity of Coronavirus Disease 2019.
    J Infect Dis. 2021;224:754-763.
    PubMed         Abstract available
    
    
29. KIM MH, Salloum S, Wang JY, Wong LP, et al
    Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity.
    J Infect Dis. 2021;224:777-782.
    PubMed         Abstract available
    
    

    
    J Virol

30. KIRCHENBAUM GA, Sautto GA, Richardson RA, Ecker JW, et al
    A competitive hemagglutination inhibition assay for dissecting functional antibody activity to influenza virus.
    J Virol. 2021 Sep 15:JVI0237920. doi: 10.1128/JVI.02379.
    PubMed         Abstract available
    
    

    
    Lancet

31. SCORRANO L, Baglivo I, Cavallo DM, Cecconi F, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:660-661.
    PubMed        
    
    
32. LIJFERING WM
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:659-660.
    PubMed        
    
    
33. ETIENNE CF
    Tackling Latin America's COVID-19 emergency requires greater solidarity.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01757.
    PubMed        
    
    
34. KALAFAT E, Magee LA, von Dadelszen P, O'Brien P, et al
    SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01756.
    PubMed        
    
    
35. PUNG R, Mak TM, Kucharski AJ, Lee VJ, et al
    Serial intervals in SARS-CoV-2 B.1.617.2 variant cases.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01697.
    PubMed        
    
    
36. YU LM, Bafadhel M, Dorward J, Hayward G, et al
    Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01744.
    PubMed         Abstract available
    
    
37. PRIESEMANN V, Balling R, Bauer S, Beutels P, et al
    Towards a European strategy to address the COVID-19 pandemic.
    Lancet. 2021 Aug 9. pii: S0140-6736(21)01808.
    PubMed        
    
    
38. LIU X, Shaw RH, Stuart ASV, Greenland M, et al
    Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01694.
    PubMed         Abstract available
    
    
39. ABBAS M, Goto M, Tartari E, Perencevich E, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661-663.
    PubMed        
    
    
40. ZHOU Q, Wang X, Estill J, Yang K, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661.
    PubMed        
    
    
41. HARVEY SB, Epstein RM, Glozier N, Petrie K, et al
    Mental illness and suicide among physicians.
    Lancet. 2021;398:920-930.
    PubMed         Abstract available
    
    
42. BOSELEY S
    The race to make a COVID-19 vaccine.
    Lancet. 2021;398:832-833.
    PubMed        
    
    
43. JERVING S
    The long road ahead for COVID-19 vaccination in Africa.
    Lancet. 2021;398:827-828.
    PubMed        
    
    
44. ROGAWSKI MCQUADE ET, Breskin A
    Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01817.
    PubMed        
    
    
45. THE LANCET
    Understanding long COVID: a modern medical challenge.
    Lancet. 2021;398:725.
    PubMed        
    
    
46. SALLES A, Jagsi R
    Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic.
    Lancet. 2021 Aug 24. pii: S0140-6736(21)01912.
    PubMed        
    
    
47. JUNI P, da Costa BR, Bobos P, Bodmer NS, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:663.
    PubMed        
    
    
48. CHU D, Khamis A, Akl E, Neumann I, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection - Authors' reply.
    Lancet. 2021;398:663-664.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

49. WANGA V, Chevinsky JR, Dimitrov LV, Gerdes ME, et al
    Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1235-1241.
    PubMed         Abstract available
    
    
50. DELAHOY MJ, Ujamaa D, Whitaker M, O'Halloran A, et al
    Hospitalizations Associated with COVID-19 Among Children and Adolescents - COVID-NET, 14 States, March 1, 2020-August 14, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1255-1260.
    PubMed         Abstract available
    
    
51. SIEGEL DA, Reses HE, Cool AJ, Shapiro CN, et al
    Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0-17 Years - United States, August 2020-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1249-1254.
    PubMed         Abstract available
    
    
52. KIRBY AE, Walters MS, Jennings WC, Fugitt R, et al
    Using Wastewater Surveillance Data to Support the COVID-19 Response - United States, 2020-2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1242-1244.
    PubMed         Abstract available
    
    
53. REBMANN T, Loux TM, Arnold LD, Charney R, et al
    SARS-CoV-2 Transmission to Masked and Unmasked Close Contacts of University Students with COVID-19 - St. Louis, Missouri, January-May 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1245-1248.
    PubMed         Abstract available
    
    

    
    N Engl J Med

54. JARA A, Undurraga EA, Gonzalez C, Paredes F, et al
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMoa2107715.
    PubMed         Abstract available
    
    
55. BRINKLEY-RUBINSTEIN L, Peterson M, Martin R, Chan P, et al
    Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2108479.
    PubMed        
    
    
56. NORMARK J, Vikstrom L, Gwon YD, Persson IL, et al
    Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2110716.
    PubMed        
    
    
57. CHU VT, Yousaf AR, Chang K, Schwartz NG, et al
    Household Transmission of SARS-CoV-2 from Children and Adolescents.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMc2031915.
    PubMed        
    
    
58. RAPEPORT G, Smith E, Gilbert A, Catchpole A, et al
    SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMp2106970.
    PubMed        
    
    
59. WILDER-SMITH A, Mulholland K
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385:946-948.
    PubMed        
    
    
60. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Round of Rising Covid-19 Numbers.
    N Engl J Med. 2021;385:e41.
    PubMed        
    
    

    
    Pediatrics

61. MAYNE SL, Hannan C, Davis M, Young JF, et al
    COVID-19 and Adolescent Depression and Suicide Risk Screening Outcomes.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    
62. KAISER SV, Watson A, Dogan B, Karmur A, et al
    Preventing COVID-19 Transmission in Education Settings.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    
63. MARSHALL M, Ferguson ID, Lewis P, Jaggi P, et al
    Symptomatic Acute Myocarditis in Seven Adolescents Following Pfizer-BioNTech COVID-19 Vaccination.
    Pediatrics. 2021 Jun 4. pii: peds.2021-052478. doi: 10.1542/peds.2021-052478.
    PubMed        
    
    
64. BISWAS L, Crain N, Spaeder MC, Gomez RJ, et al
    iciHHV-6 in a Patient With Multisystem Inflammatory Syndrome in Children.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    
65. DUARTE-SALLES T, Vizcaya D, Pistillo A, Casajust P, et al
    Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    
66. SHAIKH N, Friedlander EJ, Tate PJ, Liu H, et al
    Performance of a Rapid SARS-CoV-2 Antigen Detection Assay in Symptomatic Children.
    Pediatrics. 2021;148.
    PubMed        
    
    
67. KAMRATH C, Rosenbauer J, Eckert AJ, Pappa A, et al
    Incidence of COVID-19 and Risk of Diabetic Ketoacidosis in New-Onset Type 1 Diabetes.
    Pediatrics. 2021 May 19. pii: peds.2021-050856. doi: 10.1542/peds.2021-050856.
    PubMed        
    
    
68. SEGE RD
    Reasons for HOPE.
    Pediatrics. 2021;147.
    PubMed        
    
    
69. CURFMAN A, McSwain SD, Chuo J, Yeager-McSwain B, et al
    Pediatric Telehealth in the COVID-19 Pandemic Era and Beyond.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    
70. BONFANTE F, Costenaro P, Cantarutti A, Di Chiara C, et al
    Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers.
    Pediatrics. 2021;148.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

71. TERUEL N, Mailhot O, Najmanovich RJ
    Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants.
    PLoS Comput Biol. 2021;17:e1009286.
    PubMed         Abstract available
    
    

    
    PLoS One

72. CHAN EYS, Cheng D, Martin J
    Impact of COVID-19 on excess mortality, life expectancy, and years of life lost in the United States.
    PLoS One. 2021;16:e0256835.
    PubMed         Abstract available
    
    
73. GONZALEZ-MENDEZ R, Diaz M
    Volunteers' compassion fatigue, compassion satisfaction, and post-traumatic growth during the SARS-CoV-2 lockdown in Spain: Self-compassion and self-determination as predictors.
    PLoS One. 2021;16:e0256854.
    PubMed         Abstract available
    
    
74. CASTRO MDM, Caicedo I, Ortiz-Rojas HJ, Castillo CM, et al
    Performance verification of the Abbott SARS-CoV-2 test for qualitative detection of IgG in Cali, Colombia.
    PLoS One. 2021;16:e0256566.
    PubMed         Abstract available
    
    
75. RAHMAN MK, Gazi MAI, Bhuiyan MA, Rahaman MA, et al
    Effect of Covid-19 pandemic on tourist travel risk and management perceptions.
    PLoS One. 2021;16:e0256486.
    PubMed         Abstract available
    
    
76. EVKOSKI B, Mozetic I, Ljubesic N, Kralj Novak P, et al
    Community evolution in retweet networks.
    PLoS One. 2021;16:e0256175.
    PubMed         Abstract available
    
    
77. HARDY LJ, Mana A, Mundell L, Neuman M, et al
    Who is to blame for COVID-19? Examining politicized fear and health behavior through a mixed methods study in the United States.
    PLoS One. 2021;16:e0256136.
    PubMed         Abstract available
    
    
78. SEVTSUK A, Hudson A, Halpern D, Basu R, et al
    The impact of COVID-19 on trips to urban amenities: Examining travel behavior changes in Somerville, MA.
    PLoS One. 2021;16:e0252794.
    PubMed         Abstract available
    
    
79. NG R, Chow TYJ, Yang W
    News media narratives of Covid-19 across 20 countries: Early global convergence and later regional divergence.
    PLoS One. 2021;16:e0256358.
    PubMed         Abstract available
    
    
80. GOLDMAN N, Pebley AR, Lee K, Andrasfay T, et al
    Racial and ethnic differentials in COVID-19-related job exposures by occupational standing in the US.
    PLoS One. 2021;16:e0256085.
    PubMed         Abstract available
    
    
81. DAS GUPTA D, Kelekar U, Turner SC, Sule AA, et al
    Interpreting COVID-19 deaths among nursing home residents in the US: The changing role of facility quality over time.
    PLoS One. 2021;16:e0256767.
    PubMed         Abstract available
    
    
82. CHIBA A
    Modeling the effects of contact-tracing apps on the spread of the coronavirus disease: Mechanisms, conditions, and efficiency.
    PLoS One. 2021;16:e0256151.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

83. LU Y, Kaushal N, Huang X, Gaddis SM, et al
    Priming COVID-19 salience increases prejudice and discriminatory intent against Asians and Hispanics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
84. AASSVE A, Cavalli N, Mencarini L, Plach S, et al
    Early assessment of the relationship between the COVID-19 pandemic and births in high-income countries.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
85. WANG J, Alipour M, Soligo G, Roccon A, et al
    Short-range exposure to airborne virus transmission and current guidelines.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
86. KING HAD, Joyce MG, Lakhal-Naouar I, Ahmed A, et al
    Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
87. BROWN RA
    A simple model for control of COVID-19 infections on an urban campus.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
88. MELVIN WJ, Audu CO, Davis FM, Sharma SB, et al
    Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    

    
    Vaccine

89. PALACHE A, Rockman S, Taylor B, Akcay M, et al
    Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.
    Vaccine. 2021 Sep 11. pii: S0264-410X(21)01157.
    PubMed         Abstract available
    
    
90. THOMPSON MG, Soto G, Perez A, Newes-Adeyim G, et al
    Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019.
    Vaccine. 2021 Sep 8. pii: S0264-410X(21)00982.
    PubMed         Abstract available
    
    

    
    Virology

91. BYRD-LEOTIS L, Lasanajak Y, Bowen T, Baker K, et al
    SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.
    Virology. 2021;562:142-148.
    PubMed         Abstract available
    
    
92. TAGHIZADEH P, Salehi S, Heshmati A, Houshmand SM, et al
    Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.
    Virology. 2021;562:63-73.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: